Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

Cancer cells reprogram their metabolism to maintain viability via genetic mutations and epigenetic alterations, expressing overall dynamic heterogeneity. The complex relaxation mechanisms of nuclear spins provide unique and convertible tissue contrasts, making magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) pertinent imaging tools in both clinics and research. In this review, we summarized MR methods that visualize tumor characteristics and its metabolic phenotypes on an anatomical, microvascular, microstructural, microenvironmental, and metabolomics scale. The review will progress from the utilities of basic spin-relaxation contrasts in cancer imaging to more advanced imaging methods that measure tumor-distinctive parameters such as perfusion, water diffusion, magnetic susceptibility, oxygenation, acidosis, redox state, and cell death. Analytical methods to assess tumor heterogeneity are also reviewed in brief. Although the clinical utility of tumor heterogeneity from imaging is debatable, the quantification of tumor heterogeneity using functional and metabolic MR images with development of robust analytical methods and improved MR methods may offer more critical roles of tumor heterogeneity data in clinics. MRI/MRS can also provide insightful information on pharmacometabolomics, biomarker discovery, disease diagnosis and prognosis, and treatment response. With these future directions in mind, we anticipate the widespread utilization of these MR-based techniques in studying in vivo cancer biology to better address significant clinical needs.

[1]  P. Reimer,et al.  Contrast mechanisms in MR imaging , 1999, European Radiology.

[2]  Paul Kinahan,et al.  Radiomics: Images Are More than Pictures, They Are Data , 2015, Radiology.

[3]  A. Brodbelt,et al.  Cellularity and apparent diffusion coefficient in oligodendroglial tumours characterized by genotype , 2010, Journal of Neuro-Oncology.

[4]  M. McMahon,et al.  Developing imidazoles as CEST MRI pH sensors. , 2016, Contrast media & molecular imaging.

[5]  R. Gillies,et al.  Quantitative imaging in cancer evolution and ecology. , 2013, Radiology.

[6]  Jan Wolber,et al.  Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy , 2007, Nature Medicine.

[7]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[8]  Edward A. Randtke,et al.  Multislice CEST MRI improves the spatial assessment of tumor pH , 2017, Magnetic resonance in medicine.

[9]  E. Gottlieb,et al.  Targeting metabolic transformation for cancer therapy , 2010, Nature Reviews Cancer.

[10]  H. Rugo Antiangiogenic and Antitumor Effects of Bevacizumab in Patients With Inflammatory and Locally Advanced Breast Cancer , 2007 .

[11]  A. Lane,et al.  Ras transformation requires metabolic control by 6-phosphofructo-2-kinase , 2006, Oncogene.

[12]  M. Essig,et al.  Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. , 2001, International journal of radiation oncology, biology, physics.

[13]  Robert Rohling,et al.  MR elastography of prostate cancer: quantitative comparison with histopathology and repeatability of methods , 2014, NMR in biomedicine.

[14]  Allison S. Cleary Teamwork: The tumor cell edition , 2015, Science.

[15]  F. Gallagher,et al.  Hyperpolarized [1-13C]-Ascorbic and Dehydroascorbic Acid: Vitamin C as a Probe for Imaging Redox Status in Vivo , 2011, Journal of the American Chemical Society.

[16]  Noam Nissan,et al.  Can diffusion tensor anisotropy indices assist in breast cancer detection? , 2016, Journal of magnetic resonance imaging : JMRI.

[17]  Shingo Matsumoto,et al.  Simultaneous imaging of tumor oxygenation and microvascular permeability using Overhauser enhanced MRI , 2009, Proceedings of the National Academy of Sciences.

[18]  P. Vaupel,et al.  Tumor hypoxia and malignant progression. , 2009, Methods in enzymology.

[19]  K. Painter,et al.  Mathematical modelling of glioma growth: the use of Diffusion Tensor Imaging (DTI) data to predict the anisotropic pathways of cancer invasion. , 2013, Journal of theoretical biology.

[20]  Claudio R. Santos,et al.  SREBP Activity Is Regulated by mTORC1 and Contributes to Akt-Dependent Cell Growth , 2008, Cell metabolism.

[21]  A. Uluğ,et al.  Diagnostic utility of DTI in prostate cancer. , 2011, European journal of radiology.

[22]  Jinyuan Zhou,et al.  Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging , 2008, Magnetic resonance in medicine.

[23]  Ashish Jindal,et al.  Comparison of kinetic models for analysis of pyruvate‐to‐lactate exchange by hyperpolarized 13C NMR , 2012, NMR in biomedicine.

[24]  Franziska Hirschhaeuser,et al.  Lactate: a metabolic key player in cancer. , 2011, Cancer research.

[25]  Albert P. Chen,et al.  Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. , 2008, Cancer research.

[26]  Bernard Gallez,et al.  How does blood oxygen level‐dependent (BOLD) contrast correlate with oxygen partial pressure (pO2) inside tumors? , 2002, Magnetic resonance in medicine.

[27]  E. Haacke,et al.  Susceptibility‐Weighted Imaging of Glioma: Update on Current Imaging Status and Future Directions , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[28]  J. Winther,et al.  Non-invasive In-cell Determination of Free Cytosolic [NAD+]/[NADH] Ratios Using Hyperpolarized Glucose Show Large Variations in Metabolic Phenotypes* , 2013, The Journal of Biological Chemistry.

[29]  Kevin Camphausen,et al.  Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Carl-Fredrik Westin,et al.  The link between diffusion MRI and tumor heterogeneity: Mapping cell eccentricity and density by diffusional variance decomposition (DIVIDE) , 2016, NeuroImage.

[31]  M. Pagel,et al.  Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI , 2014, Magnetic resonance in medicine.

[32]  Meiyappan Solaiyappan,et al.  Collagen fibers mediate MRI-detected water diffusion and anisotropy in breast cancers , 2016, Neoplasia.

[33]  Amy C. Dwyer,et al.  Models and methods for analyzing DCE-MRI: a review. , 2014, Medical physics.

[34]  Donald S. Williams,et al.  Perfusion imaging , 1992, Magnetic resonance in medicine.

[35]  P. Choyke,et al.  Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. , 2009, Neoplasia.

[36]  M. Kransdorf,et al.  Radiologic evaluation of soft-tissue masses: a current perspective. , 2000, AJR. American journal of roentgenology.

[37]  John Kurhanewicz,et al.  Multi-compound polarization by DNP allows simultaneous assessment of multiple enzymatic activities in vivo. , 2010, Journal of magnetic resonance.

[38]  A. Manduca,et al.  Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. , 1995, Science.

[39]  Ferdinand Schweser,et al.  Quantitative Susceptibility Mapping Differentiates between Blood Depositions and Calcifications in Patients with Glioblastoma , 2013, PloS one.

[40]  P. Friedl Immunological techniques: Dynamic imaging of the immune system , 2004 .

[41]  A. Gregory Sorensen,et al.  Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.

[42]  P. Larson,et al.  Metabolic Imaging of Patients with Prostate Cancer Using Hyperpolarized [1-13C]Pyruvate , 2013, Science Translational Medicine.

[43]  M. Augsten Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment , 2014, Front. Oncol..

[44]  W J Niessen,et al.  Heterogeneity in DCE-MRI parametric maps: a biomarker for treatment response? , 2011, Physics in medicine and biology.

[45]  R. Gillies,et al.  Janus-faced tumor microenvironment and redox. , 2014, Antioxidants & redox signaling.

[46]  J. Folkman Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[47]  F. Cendes,et al.  Texture analysis of medical images. , 2004, Clinical radiology.

[48]  James B. Mitchell,et al.  Overhauser enhanced magnetic resonance imaging for tumor oximetry: Coregistration of tumor anatomy and tissue oxygen concentration , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Ardenkjær-Larsen,et al.  Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[50]  J. Helpern,et al.  Diffusional kurtosis imaging: The quantification of non‐gaussian water diffusion by means of magnetic resonance imaging , 2005, Magnetic resonance in medicine.

[51]  Olav Haraldseth,et al.  Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.

[52]  Bernard Gallez,et al.  Qualification of a Noninvasive Magnetic Resonance Imaging Biomarker to Assess Tumor Oxygenation , 2014, Clinical Cancer Research.

[53]  Robert J Gillies,et al.  Imaging pH and metastasis , 2011, NMR in biomedicine.

[54]  Z. Bhujwalla,et al.  Choline metabolism in malignant transformation , 2011, Nature Reviews Cancer.

[55]  G. Semenza,et al.  Uterine DCs are essential for pregnancy. , 2008, The Journal of clinical investigation.

[56]  R. Deberardinis,et al.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. , 2008, Cell metabolism.

[57]  E. Terreno,et al.  Probing treatment response of glutaminolytic prostate cancer cells to natural drugs with hyperpolarized [5‐13C]glutamine , 2015, Magnetic resonance in medicine.

[58]  U. Motosugi,et al.  Liver stiffness measured by magnetic resonance elastography as a risk factor for hepatocellular carcinoma: a preliminary case–control study , 2012, European Radiology.

[59]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[60]  R. Kauppinen,et al.  Tumour metabolomics in animal models of human cancer. , 2007, Journal of proteome research.

[61]  J. Lagendijk,et al.  Dynamic contrast-enhanced MRI for treatment response assessment in patients with oesophageal cancer receiving neoadjuvant chemoradiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[62]  M. Dewey,et al.  Fractal analysis in radiological and nuclear medicine perfusion imaging: a systematic review , 2013, European Radiology.

[63]  Bal Sanghera,et al.  Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? , 2012, Insights into Imaging.

[64]  Richard L Ehman,et al.  Magnetic resonance elastography (MRE) in cancer: Technique, analysis, and applications. , 2015, Progress in nuclear magnetic resonance spectroscopy.

[65]  Stephanie Alexander,et al.  Cancer Invasion and the Microenvironment: Plasticity and Reciprocity , 2011, Cell.

[66]  A. Jackson,et al.  Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectives. , 2008, The Lancet. Oncology.

[67]  Jing Yan,et al.  Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging , 2016, BMC Cancer.

[68]  R. Lenkinski,et al.  pH imaging of mouse kidneys in vivo using a frequency‐dependent paraCEST agent , 2016, Magnetic resonance in medicine.

[69]  John Kurhanewicz,et al.  Hyperpolarized 13C dehydroascorbate as an endogenous redox sensor for in vivo metabolic imaging , 2011, Proceedings of the National Academy of Sciences.

[70]  Shingo Matsumoto,et al.  Magnetic resonance imaging of tumor oxygenation and metabolic profile , 2013, Acta oncologica.

[71]  M Fink,et al.  Imaging anisotropic and viscous properties of breast tissue by magnetic resonance‐elastography , 2005, Magnetic resonance in medicine.

[72]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[73]  A. Acharya,et al.  Redox regulation in cancer , 2010, Oxidative medicine and cellular longevity.

[74]  D. Le Bihan,et al.  Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. , 1988, Radiology.

[75]  E. Rofstad,et al.  Temporal heterogeneity in blood supply in human tumor xenografts. , 2008, Neoplasia.

[76]  J. Settleman,et al.  Recent advances in pathway-targeted cancer drug therapies emerging from cancer genome analysis. , 2012, Current opinion in genetics & development.

[77]  J. Downward Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[78]  R. Jain,et al.  2H-nuclear magnetic resonance imaging of tumor blood flow: spatial and temporal heterogeneity in a tissue-isolated mammary adenocarcinoma. , 1992, Cancer research.

[79]  P. Lambin,et al.  Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach , 2014, Nature Communications.

[80]  Vladimir Ponomarev,et al.  Molecular Imaging of Temporal Dynamics and Spatial Heterogeneity of Hypoxia-Inducible Factor-1 Signal Transduction Activity in Tumors in Living Mice , 2004, Cancer Research.

[81]  R. Wu,et al.  A method for accurate pH mapping with chemical exchange saturation transfer (CEST) MRI. , 2016, Contrast media & molecular imaging.

[82]  Guoying Liu,et al.  Expanding the use of magnetic resonance in the assessment of tumor response to therapy: workshop report. , 2005, Cancer research.

[83]  G. Parker,et al.  Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome , 2014, Clinical Cancer Research.

[84]  James B. Mitchell,et al.  The relationship between tissue oxygenation and redox status using magnetic resonance imaging , 2012, International journal of oncology.

[85]  Ash A. Alizadeh,et al.  Toward understanding and exploiting tumor heterogeneity , 2015, Nature Medicine.

[86]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[87]  Pascal Spincemaille,et al.  Flow compensated quantitative susceptibility mapping for venous oxygenation imaging , 2014, Magnetic resonance in medicine.

[88]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[89]  O. Feron,et al.  Pyruvate into lactate and back: from the Warburg effect to symbiotic energy fuel exchange in cancer cells. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[90]  Marc S Ramirez,et al.  Kinetic Modeling and Constrained Reconstruction of Hyperpolarized [1-13C]-Pyruvate Offers Improved Metabolic Imaging of Tumors. , 2015, Cancer research.

[91]  P. Grigsby,et al.  Intratumoral Metabolic Heterogeneity of Cervical Cancer , 2008, Clinical Cancer Research.

[92]  E. Maher,et al.  Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[93]  M. Dewhirst Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress , 2009, Radiation research.

[94]  C. Zimmer,et al.  Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging. , 2003, Radiology.

[95]  T. Hirai,et al.  Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.

[96]  Himanshu Bhat,et al.  Quantitative oxygenation venography from MRI phase , 2014, Magnetic resonance in medicine.

[97]  M. V. Heiden,et al.  Targeting cancer metabolism: a therapeutic window opens , 2011, Nature Reviews Drug Discovery.

[98]  Shixiu Wu,et al.  Single-Cell Sequencing for Precise Cancer Research: Progress and Prospects. , 2016, Cancer research.

[99]  C. Dessy,et al.  Regulation of monocarboxylate transporter MCT1 expression by p53 mediates inward and outward lactate fluxes in tumors. , 2012, Cancer research.

[100]  D. Yablonskiy,et al.  Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state , 2007, Magnetic resonance in medicine.

[101]  P. Rich The molecular machinery of Keilin's respiratory chain. , 2003, Biochemical Society transactions.

[102]  M. Kanematsu,et al.  Diffusion kurtosis imaging to assess response to treatment in hypervascular hepatocellular carcinoma. , 2015, AJR. American journal of roentgenology.

[103]  R. Ehman,et al.  Magnetic resonance elastography: A review , 2010, Clinical anatomy.

[104]  F. Gallagher,et al.  Magnetic resonance imaging with hyperpolarized [1,4-13C2]fumarate allows detection of early renal acute tubular necrosis , 2012, Proceedings of the National Academy of Sciences.

[105]  R. Weinshilboum,et al.  Metabolomics: a global biochemical approach to drug response and disease. , 2008, Annual review of pharmacology and toxicology.

[106]  H. Halpern,et al.  Towards Human Oxygen Images with Electron Paramagnetic Resonance Imaging. , 2016, Advances in experimental medicine and biology.

[107]  Hans Knutsson,et al.  Cluster failure: Why fMRI inferences for spatial extent have inflated false-positive rates , 2016, Proceedings of the National Academy of Sciences.

[108]  N. Just,et al.  Improving tumour heterogeneity MRI assessment with histograms , 2014, British Journal of Cancer.

[109]  Ferdia A Gallagher,et al.  A comparison between radiolabeled fluorodeoxyglucose uptake and hyperpolarized (13)C-labeled pyruvate utilization as methods for detecting tumor response to treatment. , 2009, Neoplasia.

[110]  O. Warburg [Origin of cancer cells]. , 1956, Oncologia.

[111]  Miklós Espák,et al.  Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment. , 2015, Magnetic resonance imaging.

[112]  H. Lincet,et al.  A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. , 2012, Biochimica et biophysica acta.

[113]  Geoff J M Parker,et al.  Organ‐specific effects of oxygen and carbogen gas inhalation on tissue longitudinal relaxation times , 2007, Magnetic resonance in medicine.

[114]  E. Melhem,et al.  Diffusion kurtosis imaging: an emerging technique for evaluating the microstructural environment of the brain. , 2014, AJR. American journal of roentgenology.

[115]  A Gregory Sorensen,et al.  Diffusion and diffusion tensor imaging in brain cancer. , 2011, Seminars in radiation oncology.

[116]  N. McGranahan,et al.  The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.

[117]  E. Maher,et al.  Noninvasive assessment of isocitrate dehydrogenase mutation status in cerebral gliomas by magnetic resonance spectroscopy in a clinical setting. , 2017, Journal of neurosurgery.

[118]  Wenzhen Zhu,et al.  Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation , 2015, Oncotarget.

[119]  S. Patra,et al.  A short review on creatine–creatine kinase system in relation to cancer and some experimental results on creatine as adjuvant in cancer therapy , 2011, Amino Acids.

[120]  Giovanna Rizzo,et al.  Texture analysis of medical images for radiotherapy applications. , 2017, The British journal of radiology.

[121]  R. Franklin,et al.  ‘Why do tumour cells glycolyse?’: From glycolysis through citrate to lipogenesis , 2005, Molecular and Cellular Biochemistry.

[122]  Thomas E Yankeelov,et al.  MR Imaging Biomarkers in Oncology Clinical Trials. , 2016, Magnetic resonance imaging clinics of North America.

[123]  R. Damadian Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.

[124]  A. Haase,et al.  Quantified pH imaging with hyperpolarized 13C‐bicarbonate , 2015, Magnetic resonance in medicine.

[125]  Mikko I. Kettunen,et al.  Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose , 2013, Nature Medicine.

[126]  K. Zaner,et al.  Human tumors detected by nuclear magnetic resonance. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[127]  A. McCullough,et al.  Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing , 2013 .

[128]  R. Jain Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[129]  Chi V Dang,et al.  Cancer's molecular sweet tooth and the Warburg effect. , 2006, Cancer research.

[130]  Jing Zhang,et al.  The Histogram Analysis of Diffusion-Weighted Intravoxel Incoherent Motion (IVIM) Imaging for Differentiating the Gleason grade of Prostate Cancer , 2015, European Radiology.

[131]  Kunwei Shen,et al.  Breast Cancer: Diffusion Kurtosis MR Imaging-Diagnostic Accuracy and Correlation with Clinical-Pathologic Factors. , 2015, Radiology.

[132]  Quantitative analysis of whole‐tumor Gd enhancement histograms predicts malignant transformation in low‐grade gliomas , 2007, Journal of magnetic resonance imaging : JMRI.

[133]  F. Gallagher,et al.  Detection of tumor glutamate metabolism in vivo using 13C magnetic resonance spectroscopy and hyperpolarized [1‐13C]glutamate , 2011, Magnetic resonance in medicine.

[134]  Simon V. Avery,et al.  Microbial cell individuality and the underlying sources of heterogeneity , 2006, Nature Reviews Microbiology.

[135]  Bejoy Thomas,et al.  Principles, techniques, and applications of T2*-based MR imaging and its special applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[136]  Michael P. Lisanti,et al.  Mitochondrial dysfunction in breast cancer cells prevents tumor growth , 2013, Cell cycle.

[137]  Heinz-Otto Peitgen,et al.  Diffusion tensor imaging in primary brain tumors: Reproducible quantitative analysis of corpus callosum infiltration and contralateral involvement using a probabilistic mixture model , 2006, NeuroImage.

[138]  P. López-Larrubia,et al.  Imaging tumor hypoxia by magnetic resonance methods , 2011, NMR in Biomedicine.

[139]  P. Barker,et al.  N‐Acetyl Aspartate—A Neuronal Marker? , 2001, Annals of neurology.

[140]  James L Tatum,et al.  Hypoxia: Importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy , 2006, International journal of radiation biology.

[141]  Geoff J M Parker,et al.  Imaging Tumor Vascular Heterogeneity and Angiogenesis using Dynamic Contrast-Enhanced Magnetic Resonance Imaging , 2007, Clinical Cancer Research.

[142]  Bram Stieltjes,et al.  Prediction of treatment response in head and neck carcinomas using IVIM-DWI: Evaluation of lymph node metastasis. , 2014, European journal of radiology.

[143]  Philippe Lambin,et al.  PET-based dose painting in non-small cell lung cancer: Comparing uniform dose escalation with boosting hypoxic and metabolically active sub-volumes. , 2015, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[144]  Robert J Gillies,et al.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478. , 2005, Neoplasia.

[145]  Axel Haase,et al.  Imaging of pH in vivo using hyperpolarized 13C-labelled zymonic acid , 2017, Nature Communications.

[146]  W. Niessen,et al.  Quantification of Heterogeneity as a Biomarker in Tumor Imaging: A Systematic Review , 2014, PloS one.

[147]  C. Helms,et al.  Lipomas, lipoma variants, and well-differentiated liposarcomas (atypical lipomas): results of MRI evaluations of 126 consecutive fatty masses. , 2004, AJR. American journal of roentgenology.

[148]  N. deSouza,et al.  Relationship between imaging biomarkers of stage I cervical cancer and poor-prognosis histologic features: quantitative histogram analysis of diffusion-weighted MR images. , 2013, AJR. American journal of roentgenology.

[149]  H. Kauczor,et al.  IVIM-diffusion-MRI for the differentiation of solid benign and malign hypervascular liver lesions-Evaluation with two different MR scanners. , 2016, European journal of radiology.

[150]  Michele Guindani,et al.  Role of Increased n-acetylaspartate Levels in Cancer. , 2016, Journal of the National Cancer Institute.

[151]  Julien Verrax,et al.  Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. , 2008, The Journal of clinical investigation.

[152]  R. Deberardinis,et al.  Cancer-Specific Production of N-Acetylaspartate via NAT8L Overexpression in Non–Small Cell Lung Cancer and Its Potential as a Circulating Biomarker , 2015, Cancer Prevention Research.

[153]  Jun Liu,et al.  Preliminary Study of MR Diffusion Tensor Imaging of the Liver for the Diagnosis of Hepatocellular Carcinoma , 2015, PloS one.

[154]  T. Jang,et al.  Hyperpolarized 13C‐lactate to 13C‐bicarbonate ratio as a biomarker for monitoring the acute response of anti‐vascular endothelial growth factor (anti‐VEGF) treatment , 2016, NMR in biomedicine.

[155]  Pradeep S Rajendran,et al.  Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.

[156]  L. Cantley,et al.  Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.

[157]  G. Johnson,et al.  Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancer. , 2012, Radiology.

[158]  H. Vargas,et al.  Intravoxel Incoherent Motion-derived Histogram Metrics for Assessment of Response after Combined Chemotherapy and Radiation Therapy in Rectal Cancer: Initial Experience and Comparison between Single-Section and Volumetric Analyses. , 2016, Radiology.

[159]  Thomas Christen,et al.  Evaluation of a quantitative blood oxygenation level‐dependent (qBOLD) approach to map local blood oxygen saturation , 2010, NMR in biomedicine.

[160]  P. Lambin,et al.  Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[161]  Current measures of metabolic heterogeneity within cervical cancer do not predict disease outcome , 2011, Radiation oncology.

[162]  A. Jackson,et al.  Dynamic contrast-enhanced MRI in clinical trials of antivascular therapies , 2012, Nature Reviews Clinical Oncology.

[163]  Fu-Nien Wang,et al.  Analysis of parametric histogram from dynamic contrast‐enhanced MRI: application in evaluating brain tumor response to radiotherapy , 2013, NMR in biomedicine.

[164]  I. Sack,et al.  High Resolution Imaging of Viscoelastic Properties of Intracranial Tumours by Multi-Frequency Magnetic Resonance Elastography , 2015, Clinical Neuroradiology.

[165]  Geoff J M Parker,et al.  Preliminary study of oxygen-enhanced longitudinal relaxation in MRI: a potential novel biomarker of oxygenation changes in solid tumors. , 2009, International journal of radiation oncology, biology, physics.

[166]  P. Barker,et al.  Imaging of brain tumors: MR spectroscopy and metabolic imaging. , 2010, Neuroimaging clinics of North America.

[167]  R A Jungmann,et al.  c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[168]  A. Berns,et al.  A functional role for tumor cell heterogeneity in a mouse model of small cell lung cancer. , 2011, Cancer cell.

[169]  J. Pouysségur,et al.  Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H+ symporters , 2015, Journal of Molecular Medicine.

[170]  Hanlee P. Ji,et al.  Pan-cancer analysis of the extent and consequences of intratumor heterogeneity , 2015, Nature Medicine.

[171]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[172]  A. Manduca,et al.  MR elastography of breast cancer: preliminary results. , 2002, AJR. American journal of roentgenology.

[173]  Robert J. Gillies,et al.  A microenvironmental model of carcinogenesis , 2008, Nature Reviews Cancer.

[174]  Matthew G. Vander Heiden,et al.  Understanding the Intersections between Metabolism and Cancer Biology , 2017, Cell.

[175]  Xavier Golay,et al.  Amide proton transfer imaging of human brain tumors at 3T , 2006, Magnetic resonance in medicine.

[176]  K. Polyak,et al.  Tumorigenesis: it takes a village , 2015, Nature Reviews Cancer.

[177]  C. Thompson,et al.  Akt-dependent transformation: there is more to growth than just surviving , 2005, Oncogene.

[178]  T. Jang,et al.  Volumetric spiral chemical shift imaging of hyperpolarized [2‐13c]pyruvate in a rat c6 glioma model , 2016, Magnetic resonance in medicine.

[179]  Paul Workman,et al.  Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. , 2006, Journal of the National Cancer Institute.

[180]  Pernille R. Jensen,et al.  Magnetic resonance imaging of pH in vivo using hyperpolarized 13C-labelled bicarbonate , 2008, Nature.

[181]  H J Halpern,et al.  Oxymetry deep in tissues with low-frequency electron paramagnetic resonance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[182]  J. Waterton,et al.  Exploring ΔR2* and ΔR1 as imaging biomarkers of tumor oxygenation , 2013, Journal of magnetic resonance imaging : JMRI.

[183]  C. James,et al.  Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging , 2011, Journal of magnetic resonance imaging : JMRI.

[184]  John Kurhanewicz,et al.  Application of Good's buffers to pH imaging using hyperpolarized (13)C MRI. , 2015, Chemical communications.

[185]  Richard L Ehman,et al.  MR elastography derived shear stiffness—a new imaging biomarker for the assessment of early tumor response to chemotherapy , 2014, Magnetic resonance in medicine.

[186]  H. Shinmoto,et al.  Diffusion kurtosis imaging study of prostate cancer: Preliminary findings , 2014, Journal of magnetic resonance imaging : JMRI.

[187]  Chunlei Liu Susceptibility tensor imaging , 2010, Magnetic resonance in medicine.

[188]  Siqing Shan,et al.  The pervasive presence of fluctuating oxygenation in tumors. , 2008, Cancer research.

[189]  T. Jang,et al.  Metabolic response of glioma to dichloroacetate measured in vivo by hyperpolarized (13)C magnetic resonance spectroscopic imaging. , 2013, Neuro-oncology.

[190]  Kristen Scott,et al.  Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma , 2012, NeuroImage.

[191]  G. Tamma,et al.  Oxidative Medicine and Cellular Longevity , 2017 .

[192]  Aaron M. Coffey,et al.  15N Hyperpolarization of Imidazole-15N2 for Magnetic Resonance pH Sensing via SABRE-SHEATH , 2016, ACS sensors.

[193]  L. D. McPhail,et al.  Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis. , 2010, Radiology.

[194]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.